3 Smartest Dividend Stocks to Buy Now
When the market entered a correction in February and March,…
Buy
63
CBSH Quote, Financials, Valuation and Earnings
Last price:
$61.87
Seasonality move
:
-0.18%
Day range:
$60.93 - $62.54
52-week range:
$48.49 - $72.75
Dividend yield:
1.7%
P/E ratio:
16.09x
P/S ratio:
5.04x
P/B ratio:
2.52x
Volume:
540.8K
Avg. volume:
657.4K
1-year change:
22.84%
Market cap:
$8.3B
Revenue:
$1.7B
EPS (TTM):
$3.87
Analysts' Opinion
-
Consensus RatingCommerce Bancshares has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 6 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $69.08, Commerce Bancshares has an estimated upside of 11% from its current price of $62.24.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $65.50 representing 100% downside risk from its current price of $62.24.
Fair Value
-
According to the consensus of 7 analysts, Commerce Bancshares has 11% upside to fair value with a price target of $69.08 per share.
CBSH vs. S&P 500
-
Over the past 5 trading days, Commerce Bancshares has overperformed the S&P 500 by 1.15% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Commerce Bancshares does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Commerce Bancshares has grown year-over-year revenues for 11 quarters straight. In the most recent quarter Commerce Bancshares reported revenues of $423.1M.
Earnings Growth
-
Commerce Bancshares has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Commerce Bancshares reported earnings per share of $1.01.
Enterprise value:
-4.2B
EV / Invested capital:
--
Price / LTM sales:
5.04x
EV / EBIT:
-3.75x
EV / Revenue:
-2.50x
PEG ratio (5yr expected):
1.39x
EV / Free cash flow:
-7.81x
Price / Operating cash flow:
15.77x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
1.69%
Net Income Margin (TTM):
31.64%
Return On Equity:
16.58%
Return On Invested Capital:
16.56%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $1.5B | $1.6B | $1.7B | $400.9M | $423.1M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $3.50 | $3.47 | $3.87 | $0.80 | $1.01 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $15.5B | $20.4B | $14B | $12.8B | $13.1B | |
| Total Assets | $32.9B | $36.7B | $31.9B | $31.7B | $32B | |
| Current Liabilities | $2.1B | $3B | $2.8B | $2.9B | $2.9B | |
| Total Liabilities | $29.5B | $33.2B | $29.4B | $28.7B | $28.7B | |
| Total Equity | $3.4B | $3.4B | $2.5B | $3B | $3.3B | |
| Total Debt | $802K | $12.6M | $9.7M | $1.4M | $56K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $559.4M | $488.8M | $577.9M | $121M | -$136.7M | |
| Cash From Investing | $242.3M | $2.2B | $483.8M | $465.5M | -$484.9M | |
| Cash From Financing | -$4.2B | -$883.1M | -$372.9M | -$107.7M | $847.4M | |
| Free Cash Flow | $494.2M | $400.7M | $531.7M | $105.5M | -$150.7M | |
CBSH
Sector
Market Cap
$8.3B
$614.3M
Price % of 52-Week High
85.55%
85.46%
Dividend Yield
1.7%
1.98%
Shareholder Yield
4.91%
3.73%
1-Year Price Total Return
22.84%
7.6%
Beta (5-Year)
0.696
0.558
Dividend yield:
1.7%
Annualized payout:
$1.04
Payout ratio:
27.57%
Growth streak:
11 years
Technicals
8-day SMA
Buy
Level
$62.12
200-day SMA
Buy
Level
$61.07
Bollinger Bands (100)
Sell
Level
62.01 - 68.05
Chaikin Money Flow
Buy
Level
41M
20-day SMA
Buy
Level
$61.82
Relative Strength Index (RSI14)
Sell
Level
47.99
ADX Line
Sell
Level
15.25
Williams %R
Neutral
Level
-31.7776
50-day SMA
Sell
Level
$64.30
MACD (12, 26)
Sell
Level
-0.55
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Neutral
Level
69.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.7266)
Sell
CA Score
(Annual)
Level (-2.1333)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (1.0655)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Commerce Bancshares Inc operates as the bank holding company for Commerce Bank. The bank is engaged in the general banking business, providing a broad range of retail, mortgage banking, corporate, investment, trust, and asset management products and services to individuals, businesses, and municipalities. It operates through three segments: Consumer, Commercial, and Wealth. The Commercial segment provides corporate lending, payment solutions, leasing, international services, and business banking. The Consumer segment covers retail banking, mortgages, installment lending, and card services. The Wealth segment offers trust and estate planning, brokerage, and investment management services.
Stock Forecast FAQ
In the current month, CBSH has received 0 Buy ratings 6 Hold ratings, and 1 Sell ratings. The CBSH average analyst price target in the past 3 months is $69.08.
-
Where Will Commerce Bancshares Stock Be In 1 Year?
According to analysts, the consensus estimate is that Commerce Bancshares share price will rise to $69.08 per share over the next 12 months.
-
What Do Analysts Say About Commerce Bancshares?
Analysts are divided on their view about Commerce Bancshares share price and where it will be in the next 12 months. The majority of analysts rate the stock a Sell. However, a smaller subset of analysts suggest that Commerce Bancshares is a Buy and believe this share price will drop from its current level to $74.00.
-
What Is Commerce Bancshares's Price Target?
The price target for Commerce Bancshares over the next 1-year time period is forecast to be $69.08 according to 7 Wall Street analysts, 0 of them rate the stock a Buy, 1 rates the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is CBSH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Commerce Bancshares is a Hold. 6 of 7 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CBSH?
You can purchase shares of Commerce Bancshares via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Commerce Bancshares shares.
-
What Is The Commerce Bancshares Share Price Today?
Commerce Bancshares was last trading at $61.87 per share. This represents the most recent stock quote for Commerce Bancshares. Yesterday, Commerce Bancshares closed at $62.24 per share.
-
How To Buy Commerce Bancshares Stock Online?
In order to purchase Commerce Bancshares stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is down 17.8% over the past day.
Sell
16
PCVX alert for Apr 1
Vaxcyte [PCVX] is down 7.39% over the past day.
Sell
47
RGC alert for Apr 1
Regencell Bioscience Holdings [RGC] is down 14.68% over the past day.
